Melodiol Global Health Limited (AU:ME1) has released an update.
Melodiol Global Health Limited has announced the issuance of new ordinary shares, which were allocated without the need for a disclosure document under certain conditions of the Corporations Act. The company, specializing in cannabis and other plant-based health products, assures compliance with all necessary provisions of the Act and reports no undisclosed material information that could affect investors’ decisions. Melodiol emphasizes its commitment to product quality and broad consumer reach in the therapeutic and lifestyle sectors.
For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.
